The Penn Center for Innovation announces two key appointments to expand and enhance institution-wide innovation and technology commercialization activities
The Penn Center for Innovation (PCI) has announced two key appointments to support the next phase of its comprehensive innovation and commercialization plan.
Penn Medicine's AInSights is a cloud-based machine learning platform accessible by clinicians for real-time image analysis supporting multiple machine learning algorithms.
Y-Prize Goes to LilyLoop, a feminine product that captures menstrual flow data for improved diagnostics
LilyLoop, which proposed a commercial application for Penn’s biodegradeable moisture sensors, is the winner of the Mack Institute for Innovation Management’s 2024 Y-Prize Competition.
OmnicPath AI specializes in developing an end-to-end workflow that integrates Spatial Transcriptomics (ST) data and high-resolution histology images to predict spatial gene expression.
Weissman has partnered in building 18 mRNA-capable Good Manufacturing Practice (GMP) sites to date across the world.
In 2024, Koo and Steager sat down with Penn Today to discuss this technology’s potential not only to brush teeth, but also to diagnose and treat infectious diseases–in teeth and beyond.
In this Penn Today article, Yang explains how her inventions begin with changes on a fundamental level that can then grow into scalable and impactful products.
The Philadelphia Business Journal recently released an article about robotics growth in Philadelphia.
Penn Spinout EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD
Penn spinout EpiVario, a biotech company focusing on neuroepigenetics for addiction disorders, has acquired small molecule acetyl co-A synthetase-2 inhibitor (ACSS2i) portfolio.
Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.